![Robert Ivanhoe](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert Ivanhoe
Director/Board Member at Cynvec LLC
Profile
Robert Ivanhoe is currently the Director at Cynvec LLC since 2006.
He has a graduate degree from American University and an undergraduate degree from The Johns Hopkins University.
Robert Ivanhoe active positions
Companies | Position | Start |
---|---|---|
Cynvec LLC
![]() Cynvec LLC Pharmaceuticals: MajorHealth Technology Cynvec LLC develops oncolytic therapeutics for the treatment of cancer. It offers cancer treatment platform to activate the body’s own immune system to safely attack tumors and prevent or slow cancer recurrence. The firm develops CYN-101, a bioengineered Sindbis viral vector vaccine expressing the NY-ESO-1 tumor associated antigen for the treatment of late-stage ovarian cancer; and an immunotherapeutic vaccine for multiple possible cancer targets. The company was founded in 2004 and is headquartered in New York, NY. | Director/Board Member | 2009-09-16 |
Training of Robert Ivanhoe
The Johns Hopkins University | Undergraduate Degree |
American University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Cynvec LLC
![]() Cynvec LLC Pharmaceuticals: MajorHealth Technology Cynvec LLC develops oncolytic therapeutics for the treatment of cancer. It offers cancer treatment platform to activate the body’s own immune system to safely attack tumors and prevent or slow cancer recurrence. The firm develops CYN-101, a bioengineered Sindbis viral vector vaccine expressing the NY-ESO-1 tumor associated antigen for the treatment of late-stage ovarian cancer; and an immunotherapeutic vaccine for multiple possible cancer targets. The company was founded in 2004 and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Robert Ivanhoe